An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis, a randomized phase II study showed.

Please provide your email address to receive an email when new articles are posted on . People who took herbs prior to dermatomyositis onset had lower rates of autoantibodies. Rather than relying on ...

Please provide your email address to receive an email when new articles are posted on . Brepocitinib improved skin disease, muscle strength and functional disability for people with dermatomyositis.